Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.010
-0.010 (-0.33%)
Feb 13, 2026, 9:50 AM EST - Market open

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $41.63M in the quarter ending September 30, 2025, a decrease of -39.69%. This brings the company's revenue in the last twelve months to $192.44M, down -30.47% year-over-year. In the year 2024, Maravai LifeSciences Holdings had annual revenue of $259.19M, down -10.30%.

Revenue (ttm)
$192.44M
Revenue Growth
-30.47%
P/S Ratio
2.25
Revenue / Employee
$349,882
Employees
550
Market Cap
769.68M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group393.44M
Arvinas312.30M
Arbutus Biopharma14.61M
Janux Therapeutics10.00M
KalVista Pharmaceuticals1.43M
Revenue Rankings